Gilead Sciences Income Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 4,230.0 | 3,026.1 | 2,028.4 |
| Cost of Goods Sold | 768.8 | 433.3 | 260.3 |
| Gross Profit | 3,461.3 | 2,592.8 | 1,768.1 |
| Gross Profit Margin | 81.8% | 85.7% | 87.2% |
| SG&A Expense | 1,245.5 | 3,304.3 | 621.2 |
| Depreciation & Amortization | 51.3 | 47.3 | 35.8 |
| Operating Income | 2,164.5 | (758.8) | 1,111.1 |
| Operating Margin | 51.2% | -- | 54.8% |
| Nonoperating Income | 109.8 | 134.6 | 47.1 |
| Nonoperating Expenses | 13.1 | 20.4 | 0.4 |
| Income Before Taxes | 2,270.3 | (638.2) | 1,161.8 |
| Income Taxes | 655.0 | 551.8 | 347.9 |
| Net Income After Taxes | 1,615.3 | (1,190.0) | 813.9 |
| Continuing Operations | 1,615.3 | (1,190.0) | 813.9 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 1,615.3 | (1,190.0) | 813.9 |
| Total Net Income | 1,615.3 | (1,190.0) | 813.9 |
| Net Profit Margin | 38.2% | -- | 40.1% |
| Diluted EPS from Total Net Income ($) | 1.68 | (1.29) | 0.86 |
| Dividends per Share | -- | -- | -- |





